ABT Earnings Prediction
The chart below shows how ABT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ABT sees a -0.94% change in stock price 10 days leading up to the earnings, and a +1.56% change 10 days following the report. On the earnings day itself, the stock moves by +0.31%. This data can give you a slight idea of what to expect for the next quarter's release.
ABT Key Earning Data
ABT Earnings Analysis
Positive
Strong Organic Sales Performance: Organic sales growth exceeded 8%, excluding COVID testing sales, with adjusted earnings per share reported at $1.21.
Nutrition Sales Growth: Nutrition sales increased by 3.5%, driven by a 12% growth in U.S. pediatric nutrition and 11.5% growth in U.S. adult nutrition.
Core Diagnostics Sales Growth: Core Laboratory Diagnostics sales grew by 4.5%, excluding COVID testing, supported by global demand for routine diagnostic testing and large account wins.
MedTech Sales Surge: MedTech sales grew over 13%, with continuous glucose monitors exceeding $1.6 billion in sales, reflecting a 21% growth in the quarter.
Structural Heart Sales Growth: Structural heart sales grew more than 16%, driven by strong performance across surgical valves and transcatheter repair products, with market share gains in TAVR.
Negative
Nutrition Segment Sales Growth: Sales in the Nutrition segment increased only 3.5%, with international pediatric nutrition experiencing softness due to poor commercial execution, leading to share losses.
Core Lab Sales Growth: Core Laboratory Diagnostics sales growth was only 4.5%, negatively impacted by the implementation of the Value-Based Purchasing (VBP) program in China, which is expected to continue affecting growth.
Gross Margin Decline: Adjusted gross margin ratio decreased to 56.3% of sales, indicating potential challenges in cost management despite overall sales growth.
Currency Fluctuation Impact: The unfavorable foreign exchange impact of 2.5% on third-quarter sales highlights vulnerability to currency fluctuations, which could affect future revenue projections.
Tax Rate Impact on Earnings: The adjusted tax rate of 15% reflects a higher tax burden, which could limit net earnings growth moving forward.
ABT FAQs
How does ABT typically perform around its earnings report dates?
ABT's stock performance around earnings reports can vary, but historical data shows specific patterns, such as a -0.94% change leading up to the report and a +1.56% change in the 10 days following the release.
Is Earnings call transcript: Abbott Labs Q3 2024 sees steady growth positive or negative?
How can historical earnings data help predict future stock performance?
ABT Earning Call Sentiment
Earnings call transcript: Abbott Labs Q3 2024 sees steady growth
ABT.N
-1.07%
